Does Maternal Omega 3 Supplementation Protect Against Infantile Hypertrophic Pyloric Stenosis?

Maya Paran1, Enrique Freud1,2, Inbal Samuk1,2

  • 1Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv.

Insights

Maternal omega-3 supplement intake during pregnancy may reduce the risk of infantile hypertrophic pyloric stenosis (IHPS). This finding suggests a potential protective role for omega-3 fatty acids in IHPS development.

Area of Science:

  • Pediatrics
  • Maternal Health
  • Nutritional Science

Background:

  • Infantile hypertrophic pyloric stenosis (IHPS) is a critical condition with unknown etiology.
  • Known risk factors for IHPS exist, but research into maternal nutrition and habits is ongoing.
  • Investigating modifiable maternal factors may identify new preventative strategies for IHPS.

Purpose of the Study:

  • To evaluate the prevalence of known IHPS risk factors.
  • To explore maternal nutrition and habits as potential risk factors for IHPS.
  • To determine the association between maternal omega-3 supplement consumption and IHPS risk.

Main Methods:

  • A case-control study comparing mothers of IHPS infants with control mothers.
  • Infants diagnosed with IHPS and operated on between 2010-2016 were identified.
  • Data on risk factors, including maternal diet, were collected via questionnaires.

Main Results:

  • Maternal omega-3 supplement consumption (≥1-2 times/week) was significantly lower in IHPS cases than controls (P=0.031).
  • After adjusting for factors like male sex and maternal smoking, omega-3 intake remained linked to reduced IHPS risk (OR=0.303, P=0.02).
  • Sixty-six cases and 67 controls were analyzed.

Conclusions:

  • Maternal omega-3 supplement intake during pregnancy is associated with a significantly lower risk of IHPS.
  • These findings highlight a potential protective effect of omega-3 fatty acids against IHPS.
  • Further research is warranted to confirm these results and elucidate the underlying mechanisms.
Abstract

Related Concept Videos